Physician

Infectious Disease

Amy D. Klion, MD works in the field of Infectious Disease. She went to NYU School of Medicine. Klion has written publications. She has 44 publications published with PubMed. The lastest publication is: 'Analysis of nematode motion using an improved light-scatter based system.'

Publications

---

• Analysis of nematode motion using an improved light-scatter based system.
• Eosinophil-associated processes underlie differences in clinical presentation of loiasis between temporary residents and those indigenous to Loa-endemic areas.
• Eosinophils in vasculitis: characteristics and roles in pathogenesis.
• Development of a suspension array assay in multiplex for the simultaneous measurement of serum levels of four eosinophil granule proteins.
• Rapid development of migratory, linear, and serpiginous lesions in association with immunosuppression.
• Highly heterogeneous, activated and short-lived regulatory T cells during chronic filarial infection.
• The consequences of not having eosinophils.
• Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes.
• ICON: Eosinophil Disorders.
• Peripheral blood stem cell transplant-related Plasmodium falciparum infection in a patient with sickle cell disease.
• Interferon regulatory factor modulation underlies the bystander suppression of malaria antigen-driven IL-12 and IFN-? in filaria-malaria co-infection.
• IL-5 receptor ? levels in patients with marked eosinophilia or mastocytosis.
• Eosinophilic myeloproliferative disorders.
• Use of high-dose, twice-yearly albendazole and ivermectin to suppress Wuchereria bancrofti microfilarial levels.
• Elevated levels of plasma angiogenic factors are associated with human lymphatic filarial infections.
• Refining the definition of hypereosinophilic syndrome.
• Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy.
• Lymphocytic vasculitis involving the central nervous system occurs in patients with X-linked lymphoproliferative disease in the absence of Epstein-Barr virus infection.
• How I treat hypereosinophilic syndromes.
• A randomized trial of doxycycline for Mansonella perstans infection.
• Rapid, novel, specific, high-throughput assay for diagnosis of Loa loa infection.
• Filarial infections in travelers and immigrants.
• Year-to-year variation in the age-specific incidence of clinical malaria in two potential vaccine testing sites in Mali with different levels of malaria transmission i...
• Relapse following discontinuation of imatinib mesylate therapy for FIP1L1/PDGFRA-positive chronic eosinophilic leukemia: implications for optimal dosing.
• KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1L1/PDGFRA-associated chronic eosinophilic leukemia are distinct entities.
• Approach to the therapy of hypereosinophilic syndromes.
• Eosinophilia is associated with a higher mortality rate among patients with autoimmune lymphoproliferative syndrome.
• Filaria-induced monocyte dysfunction and its reversal following treatment.
• Selective generation of functional somatically mutated IgM+CD27+, but not Ig isotype-switched, memory B cells in X-linked lymphoproliferative disease.
• Recent advances in the diagnosis and treatment of hypereosinophilic syndromes.
• Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti-IL-5 antibody SCH55700.
• Anti-interleukin-5 therapy for asthma and hypereosinophilic syndrome.
• The etiology of severe anemia in a village and a periurban area in Mali.
• Genetic heterogeneity in Loa loa parasites from southern Cameroon: A preliminary study.
• Familial eosinophilia: a benign disorder?
• Safety and efficacy of the monoclonal anti-interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndrome.
• Platelet-derived growth factor receptor inhibition to treat idiopathic hypereosinophilic syndrome.
• Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndr...
• The role of eosinophils in host defense against helminth parasites.
• Clinical characteristics of post-treatment reactions to ivermectin/albendazole for Wuchereria bancrofti in a region co-endemic for Mansonella perstans.
• Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis...
• Serum immunoglobulin G4 antibodies to the recombinant antigen, Ll-SXP-1, are highly specific for Loa loa infection.
• A high malaria reinfection rate in children and young adults living under a low entomological inoculation rate in a periurban area of Bamako, Mali.

Schools

---

• New York University

• Johns Hopkins

• National Institute Of Health

• University Iowa

Doctors Specialties

---

• Infectious Disease Medicine
• Infectious Disease

Accepted Insurances

---

Education

---

• University of Iowa Hospitals and Clinics
• Johns Hopkins University
• NYU School of Medicine

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Netanya S. Utay, MD This Doctor is OpenDoctor Recommended.
	Dr. Larry W. Laughlin, MD This Doctor is OpenDoctor Recommended.
	Dr. Margaret Calloway, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael C. Sneller, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Irini Sereti, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Mark J. Parta, MD This Doctor is OpenDoctor Recommended.
	Dr. Henry C. Lane, MD This Doctor is OpenDoctor Recommended.
	Dr. Virginia M. Sheikh, MD
	Dr. Lauren C. Fiske, MD
	Dr. Rama Kapoor, MD This Doctor is OpenDoctor Recommended.
	Dr. Kerry E. Wilson, MD This Doctor is OpenDoctor Recommended.
	Dr. Harry W. Haverkos, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Peter M. Zawadsky Jr., MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog